Anavex Life Sciences Corp - Company Profile
Powered by
All the data and insights you need on Anavex Life Sciences Corp in one report.
- Save hours of research time and resources with
our up-to-date Anavex Life Sciences Corp Strategy Report
- Understand Anavex Life Sciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Anavex Life Sciences Corp (Anavex) that focuses on the discovery and development of novel drugs for the treatment of neurological diseases and cancer. The company's lead product: Anavex2-73, focus on research and development, and sigmaceptor technology platform are its major strengths, while operating loss carry forward could be a cause for concern. The company could benefit from orphan drug designation, growing incidence of Alzheimer’s disease in the US, and market potential: CNS therapies. Nevertheless, its performance could be affected by uncertain R&D outcomes, government regulations and competitive environment.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer